Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Proceeds from Sale and Maturity of Marketable Securities

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Proceeds from Sale and Maturity of Marketable Securities

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Proceeds from Sale and Maturity of Marketable Securities of $11.06 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-27 was $8.14M, a 1514.48% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-28 was $2.92M, a 82.40% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-27 was $3.46M, a 56.29% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-27 was $3.53M, a 86.98% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for fiscal 2025 was $9.10M, a 78.17% decline from fiscal 2024.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $41.69M, a 525.27% increase from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $6.67M, a 46.56% increase from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $4.55M, a 30.36% decline from fiscal 2021.
Period endProceeds from Sale and Maturity of Marketable Securities 3 monthProceeds from Sale and Maturity of Marketable Securities 6 monthProceeds from Sale and Maturity of Marketable Securities 6 month as first filedProceeds from Sale and Maturity of Marketable Securities 9 monthProceeds from Sale and Maturity of Marketable Securities 9 month as first filedProceeds from Sale and Maturity of Marketable Securities 12 monthProceeds from Sale and Maturity of Marketable Securities 12 month as first filed
2026-06-27$8.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$11.06M
10-Q · filed 2026-08-05
$14.52M
derived: sum of 3 quarters · filed 2026-08-05
$18.05M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28$2.92M
10-Q · filed 2026-05-07
$6.39M
derived: sum of 2 quarters · filed 2026-05-07
$9.92M
derived: sum of 3 quarters · filed 2026-05-07
$10.42M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-27$3.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$7.00M
derived: sum of 2 quarters · filed 2026-02-18
$7.50M
derived: sum of 3 quarters · filed 2026-08-05
$9.10M
10-K · filed 2026-02-18
2025-09-27$3.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$4.04M
derived: sum of 2 quarters · filed 2026-08-05
$5.64M
10-Q · filed 2025-11-05
$7.85M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28$504.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$2.11M
10-Q · filed 2026-08-05
$4.32M
derived: sum of 3 quarters · filed 2026-08-05
$31.43M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$1.60M
10-Q · filed 2026-05-07
$3.82M
derived: sum of 2 quarters · filed 2026-05-07
$30.93M
derived: sum of 3 quarters · filed 2026-05-07
$35.79M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-28$2.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$29.33M
derived: sum of 2 quarters · filed 2026-02-18
$34.19M
derived: sum of 3 quarters · filed 2026-02-18
$41.69M
10-K · filed 2026-02-18
2024-09-28$27.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$31.97M
derived: sum of 2 quarters · filed 2025-11-05
$39.47M
10-Q · filed 2025-11-05
$42.18M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-29$4.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$12.36M
10-Q · filed 2025-08-06
$15.07M
derived: sum of 3 quarters · filed 2026-02-18
$16.08M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-30$7.50M
10-Q · filed 2025-05-07
$10.22M
derived: sum of 2 quarters · filed 2026-02-18
$11.23M
derived: sum of 3 quarters · filed 2026-02-18
$12.22M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-30$2.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$3.72M
derived: sum of 2 quarters · filed 2026-02-18
$4.71M
derived: sum of 3 quarters · filed 2026-02-18
$6.67M
10-K · filed 2026-02-18
2023-09-30$1.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$2.00M
derived: sum of 2 quarters · filed 2024-11-06
$3.95M
10-Q · filed 2024-11-06
$5.40M
derived: sum of 4 quarters · filed 2025-02-19
2023-07-01$990.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$2.94M
10-Q · filed 2024-08-07
$4.39M
derived: sum of 3 quarters · filed 2025-02-19
$7.29M
derived: sum of 4 quarters · filed 2025-02-19
2023-04-01$1.95M
10-Q · filed 2024-05-09
$3.40M
derived: sum of 2 quarters · filed 2025-02-19
$6.30M
derived: sum of 3 quarters · filed 2025-02-19
$6.30M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$4.34M
derived: sum of 2 quarters · filed 2025-02-19
$4.34M
derived: sum of 3 quarters · filed 2025-02-19
$4.55M
10-K · filed 2025-02-19
2022-09-24$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$2.90M
derived: sum of 2 quarters · filed 2023-11-08
$3.10M
10-Q · filed 2023-11-08
$3.68M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-25$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$205.00K
10-Q · filed 2023-08-09
$777.00K
derived: sum of 3 quarters · filed 2024-02-14
$1.53M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-26$205.00K
10-Q · filed 2023-05-11
$777.00K
derived: sum of 2 quarters · filed 2024-02-14
$1.53M
derived: sum of 3 quarters · filed 2024-02-14
$6.74M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-25$572.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$1.33M
derived: sum of 2 quarters · filed 2024-02-14
$6.53M
derived: sum of 3 quarters · filed 2024-02-14
$6.53M
10-K · filed 2024-02-14
2021-09-25$756.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$5.96M
derived: sum of 2 quarters · filed 2022-11-02
$5.96M
10-Q · filed 2022-11-02
$11.55M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-26$5.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$5.20M
10-Q · filed 2022-08-03
$10.79M
derived: sum of 3 quarters · filed 2023-02-22
$10.92M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-27$0.00
10-Q · filed 2022-05-04
$5.59M
derived: sum of 2 quarters · filed 2023-02-22
$5.72M
derived: sum of 3 quarters · filed 2023-02-22
$8.90M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-26$5.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$5.72M
derived: sum of 2 quarters · filed 2023-02-22
$8.90M
derived: sum of 3 quarters · filed 2023-02-22
$11.40M
10-K · filed 2023-02-22
2020-09-26$129.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$3.31M
derived: sum of 2 quarters · filed 2021-11-03
$5.81M
10-Q · filed 2021-11-03
$6.74M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-27$3.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$5.68M
10-Q · filed 2021-08-04
$6.61M
derived: sum of 3 quarters · filed 2022-02-16
$6.61M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-28$2.50M
10-Q · filed 2021-05-04
$3.43M
derived: sum of 2 quarters · filed 2022-02-16
$3.43M
derived: sum of 3 quarters · filed 2022-02-16
$3.43M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-28$927.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$927.00K
derived: sum of 2 quarters · filed 2022-02-16
$927.00K
derived: sum of 3 quarters · filed 2022-02-16
$942.00K
10-K · filed 2022-02-16
2019-09-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$0.00
derived: sum of 2 quarters · filed 2020-10-29
$15.00K
10-Q · filed 2020-10-29
$5.27M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$15.00K
10-Q · filed 2020-08-05
$5.27M
derived: sum of 3 quarters · filed 2021-02-17
$5.46M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30$15.00K
10-Q · filed 2020-05-07
$5.27M
derived: sum of 2 quarters · filed 2021-02-17
$5.46M
derived: sum of 3 quarters · filed 2021-02-17
$7.27M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29$5.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$5.44M
derived: sum of 2 quarters · filed 2021-02-17
$7.25M
derived: sum of 3 quarters · filed 2021-02-17
$35.85M
10-K · filed 2021-02-17
2018-09-29$189.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$2.00M
derived: sum of 2 quarters · filed 2019-11-06
$30.59M
10-Q · filed 2019-11-06
$33.12M
derived: sum of 4 quarters · filed 2020-02-11
2018-06-30$1.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$30.41M
10-Q · filed 2019-07-31
$32.93M
derived: sum of 3 quarters · filed 2020-02-11
$36.05M
derived: sum of 4 quarters · filed 2020-02-11
2018-03-31$28.60M
10-Q · filed 2019-05-07
$31.12M
derived: sum of 2 quarters · filed 2020-02-11
$34.24M
derived: sum of 3 quarters · filed 2020-02-11
$34.59M
derived: sum of 4 quarters · filed 2020-02-11
2017-12-30$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11
$5.65M
derived: sum of 2 quarters · filed 2020-02-11
$5.99M
derived: sum of 3 quarters · filed 2020-02-11
$9.13M
10-K · filed 2020-02-11
2017-09-30$3.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$3.47M
derived: sum of 2 quarters · filed 2018-11-07
$6.60M
10-Q · filed 2018-11-07
$28.22M
derived: sum of 4 quarters · filed 2019-02-13
2017-07-01$344.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$3.48M
10-Q · filed 2018-08-08
$25.10M
derived: sum of 3 quarters · filed 2019-02-13
$43.06M
derived: sum of 4 quarters · filed 2019-02-13
2017-04-01$3.13M
10-Q · filed 2018-05-10
$24.75M
derived: sum of 2 quarters · filed 2019-02-13
$42.71M
derived: sum of 3 quarters · filed 2019-02-13
$45.09M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31$21.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$39.58M
derived: sum of 2 quarters · filed 2019-02-13
$41.95M
derived: sum of 3 quarters · filed 2019-02-13
$47.65M
10-K · filed 2019-02-13
$53.95M
10-K · filed 2017-02-14
2016-09-24$17.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$20.34M
derived: sum of 2 quarters · filed 2017-11-09
$26.04M
10-Q · filed 2017-11-09
$28.27M
10-Q · filed 2016-11-02
$21.22M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-25$2.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$8.07M
10-Q · filed 2017-08-09
$3.25M
derived: sum of 3 quarters · filed 2018-02-13
$16.46M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-26$5.70M
10-Q · filed 2017-05-10
$881.00K
derived: sum of 2 quarters · filed 2018-02-13
$14.09M
derived: sum of 3 quarters · filed 2018-02-13
$17.16M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-26-$4.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$8.39M
derived: sum of 2 quarters · filed 2018-02-13
$11.46M
derived: sum of 3 quarters · filed 2018-02-13
$19.74M
10-K · filed 2018-02-13
$27.07M
10-K · filed 2016-02-12
2015-09-26$13.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$16.27M
derived: sum of 2 quarters · filed 2016-11-02
$24.56M
10-Q · filed 2016-11-02
$29.60M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-27$3.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$11.36M
10-Q · filed 2016-08-03
$16.39M
derived: sum of 3 quarters · filed 2017-02-14
$19.54M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-28$8.29M
10-Q · filed 2016-05-04
$13.32M
derived: sum of 2 quarters · filed 2017-02-14
$16.47M
derived: sum of 3 quarters · filed 2017-02-14
$18.22M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-27$5.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$8.18M
derived: sum of 2 quarters · filed 2017-02-14
$9.93M
derived: sum of 3 quarters · filed 2017-02-14
$21.00M
10-K · filed 2017-02-14
2014-09-27$3.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$4.90M
derived: sum of 2 quarters · filed 2015-11-04
$15.96M
10-Q · filed 2015-11-04
$17.11M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-28$1.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$12.82M
10-Q · filed 2015-07-30
$13.96M
derived: sum of 3 quarters · filed 2016-02-12
$17.59M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-29$11.07M
10-Q · filed 2015-04-30
$12.21M
derived: sum of 2 quarters · filed 2016-02-12
$15.84M
derived: sum of 3 quarters · filed 2016-02-12
$17.06M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-28$1.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$4.78M
derived: sum of 2 quarters · filed 2016-02-12
$6.00M
derived: sum of 3 quarters · filed 2016-02-12
$11.58M
10-K · filed 2016-02-12
2013-09-28$3.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$4.85M
derived: sum of 2 quarters · filed 2014-10-30
$10.44M
10-Q · filed 2014-10-30
$12.04M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-29$1.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$6.81M
10-Q · filed 2014-08-07
$8.41M
derived: sum of 3 quarters · filed 2015-02-17
$10.54M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-30$5.59M
10-Q · filed 2014-04-30
$7.20M
derived: sum of 2 quarters · filed 2015-02-17
$9.32M
derived: sum of 3 quarters · filed 2015-02-17
$16.19M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-29$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
$3.73M
derived: sum of 2 quarters · filed 2015-02-17
$10.60M
derived: sum of 3 quarters · filed 2015-02-17
$25.16M
10-K · filed 2015-02-17
2012-09-29$2.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$8.99M
derived: sum of 2 quarters · filed 2013-10-30
$23.55M
10-Q · filed 2013-10-30
$27.32M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$6.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31
$21.42M
10-Q · filed 2013-07-31
$25.19M
derived: sum of 3 quarters · filed 2014-02-25
$33.11M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$14.55M
10-Q · filed 2013-05-08
$18.32M
derived: sum of 2 quarters · filed 2014-02-25
$26.25M
derived: sum of 3 quarters · filed 2014-02-25
$42.51M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$3.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$11.69M
derived: sum of 2 quarters · filed 2014-02-25
$27.95M
derived: sum of 3 quarters · filed 2014-02-25
$31.61M
10-K · filed 2014-02-25
2011-09-24$7.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$24.18M
derived: sum of 2 quarters · filed 2012-11-01
$27.84M
10-Q · filed 2012-11-01
$32.84M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-25$16.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$19.92M
10-Q · filed 2012-08-07
$24.91M
derived: sum of 3 quarters · filed 2013-02-27
$36.80M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-26$3.65M
10-Q · filed 2012-05-04
$8.65M
derived: sum of 2 quarters · filed 2013-02-27
$20.54M
derived: sum of 3 quarters · filed 2013-02-27
$25.97M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-25$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$16.88M
derived: sum of 2 quarters · filed 2013-02-27
$22.31M
derived: sum of 3 quarters · filed 2013-02-27
$72.46M
10-K · filed 2013-02-27
2010-09-25$11.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$17.32M
derived: sum of 2 quarters · filed 2011-11-02
$67.47M
10-Q · filed 2011-11-02
$68.43M
10-Q · filed 2010-11-04
$67.52M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-26$5.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03
$55.58M
10-Q · filed 2011-08-03
$56.54M
10-Q · filed 2010-08-03
$55.64M
derived: sum of 3 quarters · filed 2012-02-27
2010-03-27$50.15M
10-Q · filed 2011-05-04
$50.21M
derived: sum of 2 quarters · filed 2012-02-27
2009-12-26$55.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$50.48M
10-K · filed 2012-02-27
2009-09-26$50.43M
10-Q · filed 2010-11-04
2008-12-27$45.44M
10-K · filed 2011-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71